Categories
Feature Stories Recent News

Curaleaf Gets Approval for New Jersey Expansion

WAKEFIELD, Mass., September 11, 2020 — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading vertically integrated cannabis operator in the United States, announced today it received approval to build a new dispensary in Bordentown Township, New Jersey.

The new location, located at 191 Route 130 North, will be the company’s second dispensary in the state.

The New Jersey expansion allows Curaleaf to better serve the needs of the more than 80,000 patients enrolled in the states medical program. Construction on the more than 9,000 square foot facility is set to begin this fall and the site will open in early 2021. Like all Curaleaf dispensaries, the new location will provide patients with a destination for compassionate guidance, education, and will feature the company’s assortment of high-quality cannabis products and brands so patients can consume cannabis with ease, clarity, and confidence.

Curaleaf currently operates in 23 states with 92 dispensaries, 22 cultivation sites and over 30 processing sites. For details on Curaleaf’s dispensary location in New Jersey, along with hours of operation and contact information, please visit curaleaf.com/locations#new-jersey

About Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is the leading vertically integrated U.S. multi-state cannabis operator with a mission to improve lives by providing clarity around cannabis and confidence around consumption.

As a high-growth cannabis company known for quality, expertise and reliability, the company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets.

Curaleaf currently operates in 23 states with 92 dispensaries, 22 cultivation sites and over 30 processing sites, and employs over 3,000 team members across the United States.

Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. 

Categories
Bellmawr Feature Stories Local Government News Recent News

Focused Investment Partners, LLC Seeks Approval to Convert Harding Ave. Building into Medical Cannabis Grow & Cultivation Facility

SJO Photo

Focused Investment, Partners, LLC has filed an application seeking minor site plan approval for 136 Harding Avenue in Bellmawr. The applicant proposes to convert an existing 7,537 square foot building into Building #4 for medical cannabis grow and cultivation facility with 19 parking spaces, according to a recently published Legal Notice. The facility will be used to grow and cultivate cannabis plants for distribution by online medical marijuana vendors such as https://www.greensociety.ca/ and many others. Take note that this will only grow and maintain plants and produce medical cannabis items and not actually becoming a cannabis dispensary.

With this being said, if you are looking to open up a dispensary (if legal where you are) and the idea of growing your own products sounds like something you want to try, maybe knowing that by having equipment like Rosin Press at hand, this process may run a lot more smoothly than you may think.

Variances and waivers will be requested during the Planning Board meeting, which has been scheduled for Monday, August 5, 2019 at 7:00 p.m. in the Bellmawr Borough Hall.

The application and any other supporting documents are on file with the Board Secretary and available for inspection during regular business hours, Monday through Friday (except legal holidays) prior to the hearing.

In May, 2018, Curaleaf announced that the Bellmawr dispensary is the largest on the East Coast.

Designated as designated as Block 61, Lot 8, 136 Harding Avenue was formerly known as Block 61, Lot 8.01 and was consolidated in 2018 with Block 61, Lot 8, 111 Coolidge Avenue, and is located in the Light Industrial Zone. It last sold for $750,000.00 in November, 2018.

While doing research for this story, we learned from Mark Matthews of 42 Freeway that there is some interesting background on this property.

In the 1980’s, the 136 Harding Avenue address was used by former musician, Richard Marcus, for his “Crazy Richard’s” peanut butter.

(c) February 19, 1988 St. Joseph’s Gazette
Special thanks to Mark Matthews for providing a copy of this article.

The property was also once the address of Truxton, Inc., a pharmaceutical and medical supplier, and a family owned business since 1957.

In early, 2017, a “labeling error” traced back to Truxton, Inc. lead to a national FDA recall of Phenobarbital, a drug prescribed to young children and pets to treat epilepsy.

Categories
Bellmawr Feature Stories News Recent News

Curaleaf has Joined the New Jersey Business & Industry Association

Image Credit: Curaleaf

Curaleaf Holdings, Inc. (CSE: CURA) / OTCBB: CURLF), a leading vertically integrated cannabis operator, recently announced that is the first cannabis company to join the New Jersey Business & Industry Association (NJBIA), the nation’s largest state employer association. With over 20,000 members, the NJBIA provides information, services and advocacy to its member companies to build a more prosperous New Jersey.

Curaleaf has operated in compliance with the NJ Department of Health MMP since 2015 and remains committed to being a responsible industry leader that leverages its extensive research and development capabilities to distribute medicinal cannabis products in multiple formats with the highest standard for safety, effectiveness, consistent quality and customer care for all qualified residents of New Jersey. If you’re a medical marijuana patient and you’re needing or wanting to keep in the loop on everything regarding medical marijuana, from happy go lucky stoner news, to scientific research on the different compounds found within marijuana, whatever piques your interest this list of the best marijuana podcasts is pretty good for finding something you could enjoy in nearly every mood, sober or stoned!

Curaleaf will continue to act as a subject matter expert and resource for all the NJBIA members and other business associations in the state.

“The NJBIA is a respected organization committed to economic growth in New Jersey,” said Curaleaf New Jersey President, George Schidlovsky. “We look forward to building this partnership and receiving NJBIA’s benefits through our membership.”

NJBIA is the leading voice for small business in the state, advocating at the Statehouse every day to better advance the competitive excellence and financial success of its members. In addition to its strong advocacy in Trenton, NJBIA also offers its members a full portfolio of money-savings benefits, including a Health Benefits Solutions Program and legal hotlines, as well as a slate of great events where connections can be made. Its members employ more than one million people in the state

George Schidlovsky will also speak at NJBIA’s January 23 event – The Cannabis Economy: Are You Ready? His panel will focus on starting a cannabis business in the state. Tickets are available here.

About Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc. (CSE: CURA) / OTCBB: CURLF) is the parent of Curaleaf, Inc., a leading vertically integrated cannabis operator in the United States. Headquartered in Wakefield, Massachusetts, Curaleaf has a presence in 13 states. Curaleaf operates 42 dispensaries, 12 cultivation sites and 10 processing sites with a focus on highly populated, limited license states, including Florida, Massachusetts, New Jersey and New York.

Curaleaf leverages its extensive research and development capabilities to distribute premium cannabis products in multiple formats with the highest standard for safety, effectiveness, consistent quality and customer care. Curaleaf is committed to being the industry’s leading resource in education and advancement through research and advocacy.